Last updated: 2026-09-16 12:18:20. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
Canopy Growth Corporation (CGC) operates in the MEDICINAL CHEMICALS & BOTANICAL PRODUCTS sector and is listed on NASDAQ. The stock is currently priced at $0.92, with a market capitalisation of $396.98M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.84 to $2.38. This page covers its latest market performance, valuation, price trends and company information.
$396.98M | |
$0.93 | |
$592.50 | |
$0.77 | |
$0.92 | |
3.84K | |
3.49M | |
-- | |
$2.38 | |
$0.84 | |
-- | |
-- |
Canopy Growth Corporation (CGC) is trading at $0.92 in pre-market trading as of 2026-09-16 12:06:00, up 0.42% ($0.00) from the previous close of $0.92
Pre-market trading shows how investors are pricing CGC before the regular session opens. The current pre-market price is near the previous close, indicating positive early trading sentiment.
Over the past seven days, Canopy Growth Corporation (CGC) moved from $0.97 to $0.92, representing a decline of 5.01% ($0.05).
The stock traded between $0.91 and $1.00 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 2.20 million shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 5.2%
CGC is currently trading at $0.92, placing it 5.2% of the way from its 52-week low of $0.84 to its 52-week high of $2.38. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Canopy Growth Corp is a cannabis company that produces, distributes, and sells a diverse range of cannabis and cannabis-related products for adult-use and medical purposes under a portfolio of distinct brands in Canada. The Company supplies cannabis products in Canada, Europe, and Australia. It is focused on the medical and adult-use cannabis markets in Canada, offering a broad portfolio of brands and formats for medical cannabis patients and adult-use consumers. The Company operates through two reportable segments: Cannabis, which generates maximum revenue and includes the production, distribution, and sale of cannabis and cannabis-related products, and Storz & Bickel, which includes the production, distribution, and sale of vaporizers and accessories.
| Industry | MEDICINAL CHEMICALS & BOTANICAL PRODUCTS |
| Employees | 1128 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Canopy Growth Corporation (CGC) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.